- ￥700 - 4000
- MedChemExpress(MCE)
- 美国
- HY-15798
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
1493764-08-1
- 规格：
10 mM * 1 mL/5 mg/10 mg/50 mg
| 规格： | 10 mM * 1 mL | 产品价格： | ￥714.0 |
|---|---|---|---|
| 规格： | 5 mg | 产品价格： | ￥700.0 |
| 规格： | 10 mg | 产品价格： | ￥1200.0 |
| 规格： | 50 mg | 产品价格： | ￥4000.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
UNC2881
CAS No. : 1493764-08-1
MCE 国际站：UNC2881
产品活性：UNC2881 是一种口服有效、特异性的 Mer 激酶抑制剂，可抑制稳定状态的 Mer 激酶磷酸化，IC50 为 22 nM。UNC2881 对 Axl 和 Tyro 也有抑制作用，IC50 分别为 360 nM 和 250 nM。UNC2881 可有效抑制胶原诱导的血小板聚集，可用于血栓病理研究。
研究领域：Anti-infection | Protein Tyrosine Kinase/RTK
作用靶点：VSV | TAM Receptor
In Vitro: UNC2881 (compound 23) (0-1000 nM; 1 h) block ligand-stimulated activation of a chimeric EGFR-MerTK. UNC2881 also inhibits endogenous Mer tyrosine kinase activation in acute lymphoblastic leukemia cells.
UNC2881 (3 μM; 1 h) suppresses platelet aggregation by greater than 25% in human platelet-rich plasma in response to stimulation with fibrillar type I equine collagen.
In Vivo: UNC2881 (3 mg/kg; p.o.; single dose) has high systemic clearance (94.5 mL/min/kg) and 14% oral bioavailability, displays terminal half-life of 0.80 h.
UNC2881 (3 mg/kg; i.v.; injected with VSV on days -3, -2, -1, and 0) limits Mertk signaling, and promotes the antiviral immune response, reducing the viral replication of vesicular stomatitis virus (VSV) in infected mice.
Pharmacokinetics of UNC2881 in mice
| Route | Dose (mg/kg) | T1/2 (h) | Tmax (h) | Cmax (ng/mL) | AUClast (ng·h/mL) | CLobs (mL/min) | Vss (L/kg) | F (%) |
| IV | 3 | 0.8 | 2609 | 527 | 94.5 | 1.65 | ||
| PO | 3 | 0.30 | 90.0 | 71.7 | 14 |
相关产品：Bioactive Compound Library Plus | Kinase Inhibitor Library | Protein Tyrosine Kinase Compound Library | Anti-Cardiovascular Disease Compound Library | Orally Active Compound Library | Anti-Blood Cancer Compound Library | Targeted Diversity Library | Coagulation and Anti-coagulation Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Highly Selective Inhibitors Library | Cabozantinib | Bemcentinib | Gilteritinib | 2-D08 | UNC0638 | Dubermatinib | LDC1267 | BMS 777607 | UNC2250 | Glesatinib hydrochloride | UNC2541 | Zanzalintinib | UNC569 | Tamnorzatinib | SGI-7079 | RU-301 | Ningetinib | Tilvestamab | CEP-40783 | Octyl gallate | NPS-1034 | UNC5293 | DS-1205b free base | TAM-IN-2 | VSV-G tag Peptide | RU-302 | UNC1062 | Enapotamab
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Crystallization of Kinesin Family Motor Proteins
)(Gulick et al.,1998; Yun et al.,2001)and three KAR3 mutants (Yun et al.,2001),and KCBP (Vinogradova et al.,2004); the Kinesin-3 (formerly Unc104/KIF1)motor,KIF1A bound to different nucleotides (KIF1A-ADP,KIF1A-AMPPCP,KIF1A-ADP-Vi,KIF1A-AlFx)(Kikkawa et al
Isolation, Culture, and Differentiation of Progenitor Cells from the Central Nervous System
Isolation, Culture, and Differentiation of Progenitor Cells from the Central Nervous System Scott R. Hutton and Larysa H. Pevny1 UNC Neuroscience Center, Department of Genetics, University of North Carolina, Chapel Hill, NC 27599
9973qu6zrY//cRnNGFQHjYSpTFqYzcVwfcGpxKTCq/A/t6LYv32EgQiSd5LGiKKERGICEQEIgL7AQIidhkZ71alO122/CWbMm2qtbXJw4OUs08//bT9w1f/3v7xf37dHnn4UU3oEzEVqV61co3dcded9vnPfs5uvWmBzTn+eHv5+Rdsy7q1du6559oV3/2ezZs71558/Alpmev28K9+adu7um3jls2YJ9stt91qc045ya677lo7/PDp
技术资料暂无技术资料 索取技术资料
